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In this study Nef proteins derived from simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV) were
compared to assess their abilities to down-modulate the cell surface levels of the T-cell costimulatory molecule CD28. We
demonstrate that in addition to Nef derived from the prototypic SIVmac239, Nef proteins encoded by the pathogenic
SIVsmmPBj molecular clone and the SIVsmmB670 isolate also down-modulate cell surface CD28. In contrast, Nef proteins
derived from HIV failed to down-modulate CD28. We have also identified H196 as a critical residue which influences the
capacity of SIVmac Nef to down-modulate CD28. Nef derived from SIVmacJ5 failed to down-modulate cell surface CD28,
whereas a Q196H substitution mutant of SIVmacJ5 Nef was able to down-modulate cell surface CD28. Conversely,
substitution of H196 to Q196 in SIVmac239 Nef resulted in a mutant that had minimal effect on cell surface CD28 expression,
despite retaining the capacity to down-modulate cell surface CD3e. H196 lies immediately adjacent to a documented
di-leucine endocytic motif and mutation of this motif also abrogated the ability of SIVmac239 Nef to down-modulate CD28.
These findings demonstrate that down-modulation of the costimulatory molecule, CD28, and clonotypic TCR/CD3 complex
are conserved attributes of SIV Nef. © 2001 Academic Press
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The nef gene encodes a nonstructural, nonenzymatic
rotein, which is conserved among the primate lentivi-
uses human immunodeficiency viruses type 1 and type
2 (HIV-1 and HIV-2, respectively) and simian immunode-
ficiency virus (SIV). Nef, a 27–34 kDa protein, is N-termi-
nal myristoylated (Allan et al., 1985), has no identified
enzymatic activity, and is incorporated into virus particles
(Welker et al., 1996), increasing their infectivity. Although
Nef is not required for replication in vitro, experimental
nfections using SIV molecular clones in adult rhesus
acaques have demonstrated that Nef contributes to the
aintenance of high viral loads and accelerates disease
rogression (Kestler et al., 1991). In vitro, Nef reduces the
ell surface expression of CD4, which has been demon-
trated to prevent superinfection and may increase the
fficiency with which viral particles are released from an
nfected cell (Benson et al., 1993). Nef also increases the
ate of endocytosis of major histocompatibility class I
MHCI) molecules (Schwartz et al., 1996), which has
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148een demonstrated to protect infected cells from CTL
illing (Collins et al., 1998). Despite these data, the pre-
ise mechanism(s) by which Nef contributes to the
athogenic process in the infected host remain unclear.
Altered cellular activation is consistently associated
ith Nef expression, with both hyporesponsiveness (Lu-
ia et al., 1991; Iafrate et al., 1997) and hyperresponsive-
ess (Luo and Peterlin, 1997) having been described.
hanges in cellular activation may result as a conse-
uence of Nef’s ability to associate with cellular kinases.
IV-1 Nef interacts with multiple kinases including ty-
osine kinases (Saksela et al., 1995) and serine/threo-
ine kinases (Sawai et al., 1994; Nunn and Marsh, 1996).
umerous soluble factors as well as cell–cell contacts
nfluence the activation of T lymphocytes, a major target
or infection in the host (Zhang et al., 1999). However, the
primary mechanism for CD41 T-lymphocyte activation is
via an antigen presenting cell (APC) displaying suitable
peptide in the context of a major histocompatibility class
II (MHCII) molecule (Germain and Stefanova, 1999). Ap-
propriate MHCII/peptide ligation of the TCR a/b chains
nd additional stabilizing contacts via MHCII and CD4
esult in signal transduction through the heteromeric
D3 complex (Weiss and Littman, 1994), which consists
f g–d, g–e heterodimers, and a z–z homodimer (Clevers
et al., 1988). Naı¨ve T cells require additional signals
usually provided through the T-cell costimulatory mole-
cule CD28, which are delivered following ligation with
the counterreceptors, CD80/CD86, present on the sur-
t
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149MODULATION OF CD28 BY Nefface of professional APCs (Azuma et al., 1992). Nef’s
ability to disrupt these signalling mechanisms is evident
by our recent demonstration that SIV Nef interacts with
two domains within the TCR z chain (Schaefer et al.,
2000) and reduces cell surface expression of the TCR/
CD3 complex (Bell et al., 1998), and by demonstrations by
others that HIV-2 Nef associates with the TCR z chain
(Howe et al., 1998). Through these studies we have also
observed that SIVmac239 Nef down-modulated cell sur-
face CD28 levels while the closely related allele derived
from SIVmacJ5 failed to down-modulate CD28 (Bell et al.,
1998).
It has been proposed (Mangasarian et al., 1997) that
Nef facilitates the down-modulation of cell surface re-
ceptors by acting as a connector between these mole-
cules and intracellular trafficking machinery. Nef induces
the formation of clathrin-coated pits and there is evi-
dence indicating that Nef recruits CD4 into such clathrin-
coated pits (Foti et al., 1997). HIV-1 Nef also interacts
with a component of a vacuolar ATPase (Lu et al., 1998),
and this interaction has been linked with the ability to
down-modulate CD4. Nef has also been reported to
associate, via tyrosine-based motifs, with the m chain of
he plasma membrane adaptor complexes AP-1 and
P-2 (Lock et al., 1999), which regulate membrane-asso-
ciated protein trafficking to and from the plasma mem-
brane (Schmid, 1997). In addition, HIV-1 Nef has been
demonstrated to interact with the adaptor protein AP-2,
via a putative di-leucine motif in the C-terminal disor-
dered loop of Nef (Greenberg et al., 1998). Di-leucine
motifs are comprised of a canonical D/ExxxLf sequence,
FIG. 1. Alignment of the deduced amino acid sequences of SIV Nef
SIVmac239(open) (Kestler et al., 1990), and SIVsmmPBj14 (Saucier e
alignment. The lysine (K114) and leucine (L115) of SIVmac239 are unde
site is situated within SIVmac239/J5 Nef chimeras. The histidine (H196where “f” is generally a large, hydrophobic amino acid
(Dietrich et al., 1997).In this report, we demonstrate in transiently trans-
fected JJK T cells that multiple Nef proteins derived from
different parental SIV strains down-modulate cell surface
levels of the critical T-cell signalling molecules CD28 and
CD3e. In addition, SIVmac239 Nef reduced cell surface
xpression of a chimeric transmembrane receptor con-
aining the intracellular domain of CD28 in 293T cells,
emonstrating that this cell surface down-modulation
an occur independently of any T-cell specific factors.
ssociation of SIV Nef with CD28 was not detectable in
east two-hybrid or immunoprecipitation assays. Finally,
esidue 196 of SIVmac Nef was identified as a molecular
eterminant that distinguishes SIVmac239 Nef and SIV-
acJ5 Nef in their relative abilities to down-modulate cell
urface CD28 expression.
RESULTS
ultiple SIV Nefs down-modulate CD28 and CD3e
In previous studies of the interactions between SIV
Nef and the TCR signalling complex we observed that
SIVmac239 Nef down-modulated CD28 from the cell sur-
face, while the closely related SIVmacJ5 Nef had only
minimal effects on cell surface expression of CD28 (Bell
et al., 1998). To determine whether the ability to down-
modulate CD28 is conserved among SIV Nefs derived
from different strains of SIV, we further examined nef
alleles derived from the SIVsmmPBj molecular clone
(Saucier et al., 1998) and the SIVsmmB670 isolate (pre-
sented here) in parallel with those derived from SIV-
mac239 and SIVmacJ5. An alignment of the deduced
s. The deduced amino acid sequences of SIVmacJ5 (Rud et al., 1994),
998) and SIVsmmB670 (presented here) Nef proteins are shown in
nd indicate the protein coding position at which the introduced HindIII
Vmac239 Nef is shown boxed.protein
t al., 1
rlined aamino acid sequences of these Nef proteins is shown in
Fig. 1.
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150 BELL ET AL.The cell surface phenotypes of JJK cells transiently
transfected with expression vectors encoding SIV-
mac239, SIVmacJ5, SIVsmmPBj, and SIVsmmB670 Nef
proteins were examined by flow cytometry (Fig. 2). These
histograms indicate that SIVmac239 Nef, SIVsmmPBj
FIG. 2. Flow cytometric analysis of JJK cells transiently expressing SI
ransfected into JJK T cells. The cells were stained with fluorescently
urface staining by flow cytometry. In each histogram, the thin line rep
ith the same antibody. These data are from a single representative eNef, and SIVsmmB670 Nef down-modulated cell surface
levels of CD28, while SIVmacJ5 Nef had only minimaleffects on cell surface CD28 expression. All of these SIV
Nef proteins strongly down-modulated cell surface expres-
sion of CD3e, whereas only moderate effects on cell sur-
face CD4 expression were observed. Cell surface expres-
sion of the transferrin receptor, CD71, was not down-mod-
roteins. Plasmids encoding parental and mutant SIV Nef proteins were
antibodies 2 d after transfection, and viable cells were analyzed for
the data obtained after staining the parallel mock transfected culture
ent which was repeated a minimum of two additional times.V Nef p
labeled
resentsulated (Fig. 2), demonstrating that the reduced cell surface
expression of CD28, CD3e, and CD4 was specific.
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151MODULATION OF CD28 BY NefThe C-terminus of SIVmac Nef harbors a determinant
for down-modulation of cell surface CD28
In order to identify domains within SIVmac239 Nef that
conferred the ability to modulate cell surface levels of
CD28, we generated chimeric Nefs by exchanging por-
tions of the SIVmacJ5 and SIVmac239 nef genes. Expres-
sion constructs were generated by separately amplifying
the 59 and 39 halves of the SIVmacJ5 and SIVmac239 nef
genes. Synonymous nucleotide substitutions were intro-
duced to create a HindIII site, which was subsequently
used to ligate the 59 and 39 nef coding sequences to-
gether. Two chimeric Nef expression plasmids were gen-
erated: SIVmac239/J5 Nef, which was composed of
amino acids 1–114 of SIVmac239 Nef and amino acids
115–263 of SIVmacJ5 Nef; and SIVmacJ5/239 Nef, which
consisted of amino acids 1–114 from SIVmacJ5 Nef and
amino acids 115–263 of SIVmac239 Nef. The chimeric
Nef proteins were transiently expressed in JJK cells and
48-h posttransfection the cell surface levels of CD28,
CD3e, CD4, and CD71 were analyzed by flow cytometry.
s demonstrated in Fig. 2, both of the chimeric Nef
roteins were able to down-modulate cell surface levels
f CD3e. Whereas the SIVmacJ5/239 Nef chimera down-
odulated cell surface levels of CD28, SIVmac239/J5 Nef
ad little effect on cell surface CD28 expression. These
esults indicate the molecular determinants that confer
he ability to down-modulate cell surface CD28 levels
eside in the C-terminal region (amino acids 115–263) of
IVmac Nef.
In order to further map the determinant(s) within the
-terminus of SIVmac Nef which contribute to the down-
odulation of cell surface CD28, we performed site-
irected mutagenesis on the SIVmacJ5 and SIVmac239
ef genes. Within the C-terminus of SIVmacJ5 Nef there
re six amino acids that differ from SIVmac239 Nef, of
hich four are conserved among SIVmac239,
IVsmmPBj, and SIVsmmB670. Histidine 196 (H196) was
candidate for mutagenesis for several reasons. H196 is
onserved among SIVmac239, SIVsmmPBj, and
IVsmmB670 Nef proteins, whereas in SIVmacJ5 Nef this
esidue is a glutamine. H196 also lies adjacent to a
utative di-leucine motif, L194/M195, which has previ-
usly been demonstrated to play a role in the down-
odulation of cell surface CD4 (Bresnahan et al., 1998).
n addition, there is evidence suggesting that H196 is
mportant during replication in the host, as Nef sequence
volution studies have demonstrated selective pressure
n vivo for H196. Examinations of the evolution of SIVmac
ef sequences in rhesus macaques experimentally in-
ected with the SIV molecular clones SIVmacC8 (What-
ore et al., 1995) and SIVmac BK-41 (Lafont et al., 2000)
have demonstrated that there are high and rapid rates of
reversion from Q196 to H196. Therefore, we mutated
residue 196 and generated the SIVmacJ5 Nef Q196H and
SIVmac239 Nef H196Q substitution mutants. These Nefmutants were transiently expressed in JJK cells and cell
surface levels of CD28, CD3e, and CD4 were examined
8-h posttransfection. The histograms indicate that the
IVmacJ5 Nef Q196H mutant had gained the ability to
own-modulate cell surface CD28 while maintaining the
bility to down-modulate CD3e (Fig. 2). Importantly, the
SIVmac239 Nef H196Q mutant had minimal effects on
cell surface CD28 despite being highly effective at down-
modulating cell surface levels of CD3e. These data there-
ore demonstrate that amino acid 196 is an important
eterminant for SIV Nef-mediated down-modulation of
ell surface CD28.
While the down-modulation of CD3e by SIV Nef was
clearly extensive, the reduction of cell surface CD28 was
not as strong (Fig. 2). To examine whether the differing
abilities of SIVmacJ5, SIVmac239, and SIVmac Nef mu-
tants to down-modulate CD28 could be due to differ-
ences in transfection efficiency or steady state expres-
sion levels, the Nef coding sequences were subcloned
into pEGFP-N3 to generate N-terminal Nef/C-terminal
EGFP fusion protein expression vectors. An advantage of
using EGFP fusion proteins is that the EGFP can be used
to determine the relative levels of Nef-EGFP fusion pro-
tein expression in two-color flow cytometric analyses. JJK
cells transfected with plasmids encoding Nef-EGFP fu-
sion proteins were analyzed by two-color flow cytometry
at 48-h posttransfection. The results of these studies are
presented in Fig. 3 and confirm that the observed inabil-
ity of SIVmacJ5 to down-modulate CD28 is not a conse-
quence of low transfection efficiency or low level expres-
sion of protein, as evidenced by the relatively unchanged
level of anti-CD28-PE signal in the third and fourth de-
cades of fluorescence intensity for SIVmacJ5 Nef-EGFP.
These results further demonstrate the importance of
H196 for CD28 modulation, as the EGFP fusion of the
SIVmacJ5 Nef Q196H mutant down-modulated CD28,
while the SIVmac239 Nef H196Q mutant did not (Fig. 3).
Given that H196 lies immediately adjacent to a puta-
tive di-leucine motif, L194M195, which has previously
been reported to be necessary for SIV Nef-mediated
down-modulation of CD4 (Bresnahan et al., 1998), we
examined the ability of a SIVmac239 Nef L194A,M195A
mutant to down-modulate CD28. The two-color flow cy-
tometric analysis of this mutant indicated that this endo-
cytic motif was required for down-modulation of CD28
and CD4, while its ability to down-modulate CD3e and
the TCRa/b complex remained intact (Fig. 3). In contrast,
a mutant of SIVmac239 Nef in which the PxxP motif
(P104,P107), which is necessary for association with SH3
domains (Khan et al., 1998), was mutated to A104 and
A107, was able to down-modulate cell surface expres-
sion of CD28, CD3e, TCRa/b, and CD4.
The effects of HIV Nef-EGFP fusion proteins on T-cell
surface signalling proteins were also examined and in-
1cluded nef alleles derived directly from HIV-1 patient
materials (Michael et al., 1995) and from an HIV-2 virus
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153MODULATION OF CD28 BY Nefstock (Barnett et al., 1993). These data demonstrated that
while the HIV-1 Nefs down-modulated cell surface ex-
pression of CD4, no appreciable effects on cell surface
expression of CD3e, TCR a/b, or CD28 could be ob-
served (Fig. 3). While HIV-2 UC1 Nef had no effect on cell
surface CD28 expression, it is apparent from these stud-
ies that the steady state expression level of HIV-2 UC1-
EGFP fusion protein was considerably less than that of
the HIV-1 and SIV Nef-EGFP fusion proteins.
SIV Nef does not specifically associate with the
CD28 cytoplasmic tail in yeast two-hybrid
and co-immunoprecipitation assays
The differing abilities of SIVmacJ5 and SIVmac239
Nefs to down-modulate cell surface CD28 expression
might be due to differences in their respective abilities to
associate directly with the cytoplasmic tail of CD28. The
yeast two-hybrid assay provides a qualitative method for
analyzing if there is a direct interaction between a given
protein pair. We stably expressed SIVmacJ5, SIVmac239,
SIVsmmPBj, and SIVsmmB670 Nefs as Gal4 DNA bind-
ing domain (BD) fusion proteins in the Y190 strain of
Saccharomyces cerevisiae. These individual yeast
strains were then used to transiently express the cyto-
plasmic tails of CD28 or human TCR z as Gal4 activation
omain (AD) fusion proteins. When there is interaction
etween the SIV Nef-Gal4 BD fusion protein and a Gal4
D fusion protein, transcription of the b-galactosidase
gene is induced and the transformants can be assayed
for b-galactosidase activity. The results of these analy-
ses are presented in Table 1 and demonstrate that
whereas all SIV Nefs examined interacted with TCR z,
they all failed to interact with CD28.
It is conceivable that SIV Nef might interact with a
phosphorylated form of the cytoplasmic tail of CD28 or
associate via a bridging cellular intermediate. Either of
these mechanisms could account for the failure to ob-
serve an interaction in the yeast two-hybrid assay. We
therefore examined the ability of SIVmac Nef to associ-
ate with the cytoplasmic tail of CD28 in transiently trans-
T
Yeast Two-Hybrid Analysis of Interac
AD fusion
Gal
SIVmacJ5 Nef/BD SIVmac239 Nef/BD
CD28/AD 2a 2
Humz/AD 1 1
AD only 2 2
a 2, no detectable b-galactosidase activity in the freeze-fracture, filtfected 293T cells. However, attempts to co-immunopre-
cipitate transiently expressed SIV Nef-EGFP fusion pro-
m
tteins associated with a coexpressed CD8/CD28 fusion
protein failed to demonstrate a specific association with
the CD28 cytoplasmic tail (data not shown).
Interactions between SIVmac239 Nef and the cyto-
plasmic tail of CD28 could be dependent on a T-cell
specific factor, and this might have accounted for our
inability to specifically immunoprecipitate SIVmac Nef-
EGFP expressed in 293T cells. Therefore, the capacity of
SIVmac Nef to down-modulate cell surface expression of
CD8/CD28 fusion proteins was examined in transiently
transfected 293T cells. We have previously demonstrated
that cell surface expression of a CD8/TCR z fusion pro-
tein (CD8/Humz) is down-modulated by SIVmacJ5 Nef in
293T cells (Schaefer et al., 2000). Flow cytometric anal-
yses of transiently transfected 293T cells demonstrated
that SIVmac239 Nef was capable of reducing the cell
surface expression of both CD8/CD28 and CD8/Humz
fusion proteins (Fig. 4). In contrast, SIVmacJ5 Nef down-
modulated the cell surface expression of only the CD8/
Humz fusion protein, but failed to reduce the cell surface
expression of the CD8/CD28 fusion protein. As expected,
cell surface expression levels of the control fusion pro-
tein, CD8/Humz 127–164, with which SIV Nef does not
nteract (Schaefer et al., 2000), were not down-modulated
y SIVmacJ5 Nef or SIVmac239 Nef. These data demon-
trated that SIVmac239 Nef was able to down-modulate
cell surface transmembrane protein containing the
D28 cytoplasmic domain in the absence of T-cell spe-
ific factors, but we were unable to demonstrate asso-
iation between SIVmac239 Nef and CD28.
DISCUSSION
We have presented further evidence that Nef is an
xtremely versatile immunomodulatory viral protein. In
ddition to the well-documented ability of Nef to down-
odulate CD4, we have demonstrated that multiple SIV
efs down-modulate the T-cell costimulatory molecule,
D28, as well as CD3e, a component of the TCR/CD3
omplex. We have mapped a determinant, amino acid
96, for the contrasting abilities of SIVmac239 and SIV-
etween SIV Nef and CD28 or TCRz
binding domain fusion
SIVsmmPBj Nef/BD SIVsmmB670 Nef/BD BD only
2 2 2
1 1 2
2 2 2
ssay; 1, detectable b-galactosidase activity.ABLE 1
tions b
4 DNAacJ5 Nef to down-modulate cell surface CD28. Substi-
uting the histidine at position 196 of SIVmac239 Nef to a
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154 BELL ET AL.glutamine diminishes CD28 down-modulation, while
changing glutamine at position 196 of SIVmacJ5 Nef to a
histidine enhances CD28 down-modulation.
The observation that SIV Nef proteins derived from
diverse viral origins and which differ in their primary
sequence are able to down-modulate CD28, CD3e, and
D4 suggests that there is selective pressure in vivo to
maintain these activities. Evidence supporting the con-
tention that selective pressures exist in the host for H196
are provided by two separate studies which examined
the sequence evolution of SIV Nef in vivo. Whatmore et
al. (1995) examined the evolution of the attenuated mo-
lecular clone SIVmacC8, which is isogenic to the patho-
FIG. 4. SIVmac239 Nef down-modulates a CD8/CD28 fusion protein
in the absence of any T-cell specific factors. The 293T cell line was
cotransfected with plasmids encoding either SIVmacJ5 Nef, SIVmac239
Nef, or an anti-sense control plasmid, as well as the indicated CD8
fusion protein. Two days after transfection cells were stained for cell
surface CD8. These data are from a single representative experiment
which was repeated a minimum of two additional times. Each set of
histograms represent the antisense control (black line with light gray
fill), SIVmac239 Nef (thin black line), and SIVmacJ5 Nef (bold gray line)
transfections.genic molecular clone SIVmacJ5, except for a 12-nucle-
otide deletion and two nonsynonymous nucleotide sub-
d
lstitutions within the C-terminus of nef (Rud et al., 1994).
Two macaques examined in this study developed high
viral loads and disease, and during the course of both
infections the SIVmacC8 nef gene evolved to repair the
12-nucleotide deletion and substitute Q196 with a histi-
dine. In a separate study, the attenuated SIVmacBK28-41
molecular clone, which contains a single nucleotide de-
letion near the 39 end of nef, repaired the Nef open
reading frame in 11 out of 12 experimentally infected
macaques (Lafont et al., 2000). Of these 11 animals, 9
harboured SIV nef genes encoding Q196H substitutions.
It is conceivable that the selective pressures on SIV Nef
to contain H196 are in part due to the positive role H196
plays in SIV Nef-mediated CD28 down-modulation.
The mechanism(s) by which SIV Nef reduces cell sur-
face levels of CD28 remains unclear. Although we were
able to demonstrate association of SIV Nef with the TCR
z chain in yeast two-hybrid and coprecipitation assays,
o specific association between SIVmac Nef and the
ytoplasmic tail of CD28 could be demonstrated in par-
llel analyses. The inability to detect a specific associa-
ion between SIV Nef and CD28 may be the conse-
uence of a low affinity, yet nevertheless functionally
ignificant interaction. A previous study, in which the cell
urface down-modulation of CD28 was examined follow-
ng antibody cross-linking, has implicated the lipid ki-
ase phosphatidylinositol 3-kinase (PI-3K) in the endo-
ytosis of CD28 (Cefai et al., 1998). In these studies,
D28 complexes containing PI-3K were preferentially
ndocytosed via the clathrin-coated pit pathway. Follow-
ng endocytosis CD28 segregated into two distinguish-
ble pools, with a portion shuttled for degradation via the
ysosomal pathway and the remainder recycled back to
he cell surface. SIV Nef might enhance the endocytosis
f CD28 from the cell surface. Alternatively, SIV Nef might
ssociate with endocytosed CD28 complexes within
lathrin-coated pits and subsequently affect the fate of
he intracellular pool of CD28 by promoting trafficking to
ysosomal compartments or by inhibiting the recycling of
D28 back to the cell surface. Identifying the precise
echanism by which SIV Nef modulates CD28 expres-
ion will require further analysis.
H196 is located adjacent to a documented di-leucine
ndocytic motif, which is conserved among HIV-1, HIV-2,
nd SIV Nef sequences. This di-leucine motif has been
emonstrated to facilitate the association of HIV-1 Nef
ith the adaptor protein AP-2 and contribute to CD4
own-modulation (Bresnahan et al., 1998). SIV Nef con-
ains a C-terminal di-leucine motif, as well as additional
-terminal tyrosine-based sorting motifs that also con-
ribute to CD4 down-modulation (Lock et al., 1999). The
echanism by which SIV Nef mediates down-modulation
f cell surface CD28 or routes endocytosed CD28 for
egradation is clearly dependent on the C-terminal di-
eucine motif (see SIVmac239 Nef L194A,M195A; Fig. 3).
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155MODULATION OF CD28 BY NefMutation of this motif abrogated the ability to down-
modulate CD28 and severely reduced the ability to
down-modulate CD4, but had no impact on the ability to
down-modulate the TCR/CD3 complex. The role played
by H196 might be more complex than simply as a com-
ponent of the L194, M195 di-leucine motif, because the
SIVmac239 Nef H196Q mutant maintained the ability to
down-modulate CD4, though it was unable to apprecia-
bly down-modulate CD28 (Fig. 3).
Ligation of the TCR/CD3 complex is required for acti-
vation of mature T-lymphocytes, while additional co-
stimulation through CD28 is also necessary for activation
of naı¨ve T-lymphocytes (Janeway and Bottomly, 1994). It
has been proposed that the rate at which TCRs are
engaged by an MHCII/peptide ligand can qualitatively
affect T-cell activation (Valitutti and Lanzavecchia, 1997).
It is likely that expression of Nef, which reduces the
availability of these receptors at the cell surface, will
impair the infected CD41 T lymphocyte’s ability to re-
pond to antigenic stimulation. Reducing the ability of an
nfected cell to respond to presented antigens may result
n that cell returning to a resting or quiescent state. It has
ecently been demonstrated that SIV and HIV-1 replicate
ot only in activated T-lymphocytes, but also in lympho-
ytes lacking activation markers including CD25, CD71,
D30, CD38, and CD134 (Zhang et al., 1999). It is possi-
le that by reducing the ability of an infected cell to be
ctivated, Nef reduces the rate of virus production from
hat cell, but total virus production by that cell may be
reater if this permits virus particles to be produced over
longer period of time. The observation that SIV Nef
educes the cell surface expression of T-cell surface
ntigens including CD28, the clonotypic TCR/CD3 com-
lex, and CD4, all of which contribute to antigen-driven
D41 T-cell activation, indicate that impairing the ability
f the infected cell to respond to antigenic stimulation is
ikely to be in some way advantageous to the virus.
uture in vivo studies are necessary to dissect whether
hese mechanisms benefit SIV as a consequence of
mmunological impairment of CD41 T-lymphocyte re-
sponses or whether the benefit is to simply extend the
time period during which an infected cell can produce
virus.
MATERIALS AND METHODS
Cells, transfections, and flow cytometry
The CD41, CD281 Jurkat T-cell line JJK (kindly provided
by Dr. D. Littman, NYU Medical Center) was maintained
in RPMI 1640 supplemented with 5 mM L-glutamine and
10% foetal calf serum (FCS). 293T cells (ATCC) were
maintained in DMEM supplemented with 2 mM glu-
tamine and 5% FCS. JJK and 293T cells were transfected
by electroporation using a Bio-Rad Gene Pulser II appa-
ratus. Cell staining and flow cytometry methods wereperformed as previously described (Bell et al., 1998;
Schaefer et al., 2000).
Generation of vectors encoding mutated Nefs
Chimeric SIV Nefs were generated by polymerase
chain reaction (PCR) with Pfu polymerase (Stratagene).
pSA90SIVmacJ5Nef and pSA90SIVmac239Nef were used
as templates. Sequences encoding the 59 portion [nucle-
otides (nt) 1–342] of the SIVmacJ5 nef (Rud et al., 1994)
and SIVmac239 nef (Kestler et al., 1990) were generated
using the primers 59SNef (59-ACACGAATTCAATGGGTG-
GAGCTATTTCC-39) and NefHindR (59-TGCAAGCTTGTA-
ACTCATTGTTC-39). These PCR products were digested
with EcoRI and HindIII, then cloned into appropriately
prepared pSP72 (Promega), and DNA sequenced. The 39
portion (nt 343–792) of SIVmacJ5 nef was generated by
PCR using the primers NefHindIIIFJ5 (59-TGAGTTA-
CAAGCTTGCAGTAGATATGTCT-39) and 39SNef (59-
ACACTCGAGGAATTCTCAGCGAGTTTCCTTCTTGT-39).
Similarly, the 39 portion (nt 1–342) of SIVmac239 nef was
generated using the primers NefHindIIIF239 (59-
TGAGTTACAAGCTTGCAATAGACATGTCT-39) and 39SNef.
These PCR products were restriction digested with Hin-
dIII and XhoI and then cloned into appropriately prepared
pSP72. pSP72 vectors containing appropriate 59 nef por-
tions were digested with HindIII and XhoI and the 39
portions were then subcloned in as HindIII/XhoI frag-
ment. The resulting constructs contained chimeric nef
open reading frames with synonymous nucleotide sub-
stitutions, which resulted in the introduction of a unique
HindIII site at amino acid positions 114/5. These nef
genes were subsequently subcloned as EcoRI fragments
into the mammalian expression vector pSA90, previously
named pGW1HG (Chapman et al., 1991).
The Q196H mutant of SIVmacJ5 Nef was generated by
overlap extension PCR. pSA90SIVmacJ5Nef was used as
template with 59SNef and 196QHR (59-GGAAGTTT-
GAGCTGG[A/C]TGCATTAAATAATG-39) to generate the 59
nef portion (nt 1–602) while primer pair 196QHF (59-
CATTATTTAATGCA[G/T]CCAGCTCAAACTTCC-39) and
39SNef were used to generate the 39 nef portion (nt
573–792). These amplified products were combined in a
final PCR with the primer pair 59SNef and 39SNef to
generate the full-length SIVmacJ5 Q196H nef mutant. The
same combinations of primers were used to generate
SIVmac239 H196Q nef, which was accomplished by en-
gineering 196QHF and 196QHR to contain a degenerate
base at nt 588.
A plasmid encoding SIVmac239 Nef as a fusion protein
with EGFP at its C-terminus, pEGFP239Nef, was generated
using Pfu polymerase to amplify the SIVmac239 nef open
reading frame from pSA90SIVmac239Nef plasmid with
primers 59SNef and 3SNefGFP (59-ACACGGATCCGC-
GAGTTTCCTTCTTGTC-39). The amplified product was di-
gested with EcoRI and BamHI and then subcloned into
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156 BELL ET AL.appropriately prepared pEGFP-N3 vector (Clontech).
pEGFPJ5Nef has previously been described (Bell et al.,
1998).
A plasmid encoding SIVmac239 nef, containing muta-
tions of amino acids L194 and M195 to alanines, fused to
EGFP was generated by overlap extension PCR. pSA90.239
nef open.7.1 was used as template with primers 59SNef and
39LLAAR (59-TGGATGTGCTGCATAATGCTCCTCATCCTC-
9) to generate the 59 half and primers 239LLAAF (59-
ATTATGCAGCACATCGAGCTCAAACTTCCCAG-39) and
9SNefGFP to generate the 39 half. These amplified prod-
cts were combined in a final PCR reaction with primers
9SNef and 39SNefGFP to generate the full-length SIV-
ac239 LM/AA nef mutant. The PCR product was restric-
ion digested with enzymes EcoRI and BamHI, then cloned
nto appropriately prepared pEGFP-N3, and DNA se-
uenced. A plasmid encoding SIVmac239 nef, containing
utations of amino acids P104 and P107 to alanines, fused
o EGFP was generated by overlap extension PCR.
SA90.239 nef open.7.1 was used as template with primers
9SNef and 239PPAA (59-GCGCAAGCTTGTAACTCATTGT-
CTTAGGGCAACTTTTGCCCTCACTGA-39) to generate 59
alf. This amplified product was restriction digested with
nzymes HindIII and EcoRI and then cloned into appropri-
tely prepared pSP72 which contained the 39 half of the
arental SIVmac239 nef. This DNA was then used as tem-
late to generate a mutant lacking the 39 stop codon.
rimers 59SNef and 39SNefGFP were used to amplify the
ull-length SIVmac239 PxxP/AxxA nef mutant insert, which
as then EcoRI and BamHI digested, cloned into appropri-
tely prepared pEGFP-N3 vector, and DNA sequenced.
CR, subcloning, and sequencing of HIV nef genes
The original templates for amplification of HIV-1 nef
lleles were kindly provided by Dr. N. Michael (Walter
eed Army Institute of Research) (Michael et al., 1995)
nd the virus stock for amplification of HIV-2 nef was
indly provided by Dr. J. Levy (University of California,
an Francisco) (Barnett et al., 1993). Plasmids encoding
IV-2 and HIV-1 Nef-EGFP fusion proteins were gener-
ted by PCR with the following primers and templates.
or HIV-2 UC1 Nef, primers HIV2UC159 (59-CGCGAATTC-
ATGGGATCAGCTGGTTCC-39) and H2NEFGFP (59-
CACGGATCCCTCCTTCTCTGGTAATCC-39) were used
ith HIV2.UC1.pGEX.13 as template. For HIV-1 IP2-307
ef, primers HIVNef59 (59-CGCGAATTCCATGGGTGGCA-
GTGGTCA-39) and HNefIPGFP (59-ACACGGATCCG-
AGTCTTTGTAGTACTC-39) were used with pSA90.
P2.307.20 as template. For HIV-1 SP1-102 Nef, primers
IVNef59 and HNefSPGFP (59-ACACGGATCCGCAGT-
CTTGTAGTACTC-39) were used with pSA90.SP1.102.10
s template. Amplified products were restriction di-
ested with enzymes EcoRI and BamHI, ligated to ap-
ropriately prepared pEGFP-N3, and DNA sequenced.CR, subcloning, and sequencing of SIVsmm
ef genes
The PBj nef gene was obtained by digesting pBK-6.6
Saucier et al., 1998) (kindly provided by Dr. S. Dewhurst,
niversity of Rochester) with EcoRI and XbaI restriction
nzymes. The recessed 39 termini of the PBj nef gene
ragment were filled in using the Klenow fragment of
scherichia coli DNA polymerase I, and the fragment
as gel isolated and subcloned into pYTH9. The PBj nef
ene was subsequently reamplified with the primers
BJFor (59-ACACGAATTCAATGGGTGGCGTTACCTCC-39)
nd PBJRev (59-ACACGAATTCCTAGCTTGTTTTCTTCTT-
TC-39), digested with EcoRI, and subcloned into appro-
riately prepared pSA90 vector.
Virus particles contained in a 1-ml cryopreserved ali-
uot of SIVsmmDB670 (stock Rh II, kindly provided by Dr.
. Murphey-Corb, University of Pittsburgh) were col-
ected by centrifugation at 13,000 g for 1 h and viral RNA
as purified using TRIzol reagent (GIBCO/BRL). Viral
NA was reverse-transcribed to cDNA using random
examers and MuLV reverse transcriptase (PE Biosys-
ems, Foster City, CA). The resulting cDNA was serially
iluted and a 795-bp product spanning the nef gene was
mplified by nested PCR. First-round PCR products were
enerated with primers pnef2 (59-TGATTCGCCTCTT-
ACTTGGCTAT-39) and LTRd (59-CCAGGCGGCGACTAG-
AGAGATGGGAACA-39) for 30 cycles of annealing at
0°C and extension at 72°C for 1.5 min. Second-round
CRs were performed using 1 ml of product from the first
ound and primers TR1 (59-CCGAACCTTGAATTCCAT-
GGTGCCGCTGGTTCC-39) and TR2 (59-CCGGAATTCA-
ATCTCTCGAGTCAGCTTGTTTCCTTCTTGTC-39), for 30
ycles with annealing at 50°C and extension for 1 min at
2°C. The highest dilution of cDNA that resulted in a PCR
roduct was determined, and additional PCR products
ontaining the nef gene were generated from that dilu-
ion of cDNA. PCR products were cloned into the pCR2.1
loning vector (Invitrogen, Carlsbad, CA) and inserts
ere DNA sequenced. Plasmid expression vectors con-
aining SIVsmmDB670 nef alleles were generated by
restriction digestion of pCR2.1/nef cloning vectors with
EcoRI or BglII/HindIII, agarose gel purification of re-
leased inserts, and ligation to appropriately prepared
pSA90 or pYTH9 vectors, respectively.
Generation of CD28 expression vectors
Primers CD28F.CY (59-ACACGGATCCTGAGTAAGAG-
GAGCAGGCTCC-39) and CD28R.3PCS (59-ACACCTC-
GAGTCAGGAGCGATAGGCTGCGA-39) were designed to
amplify the sequence encoding the cytoplasmic domain
of CD28. These primers were used in a reverse transcrip-
tion reaction using the ACCESS RT-PCR system (Pro-
mega) in conjunction with mRNA isolated from JJK T cells
using the PolyATract System 1000 (Promega). The ampli-
fied sequence was cloned into pGemT (Promega), DNA
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157MODULATION OF CD28 BY Nefsequenced, and subcloned as an EcoRI/XhoI fragment
into appropriately prepared pACT2 (Clontech) and
pCDNA3.1CD8 (Schaefer et al., 2000) vectors.
Generation and analysis of yeast strains
All manipulations of the Y190 strain of S. cerevisiae
(Harper et al., 1993) followed standard yeast genetic
methods (Johnston, 1994). Recombinant yeast strains
stably expressing fusion proteins of the Gal4 DNA bind-
ing domain and SIVmacJ5, SIVmac239, SIVsmmPBj,
SIVsmmB670 Nef (Nef/BD) were generated by targeted
integration of XbaI-linearized (J5, 239, PBj Nef) and un-
linearized (B670 Nef) Gal4 BD vectors into the trp1 locus
of strain Y190 as described (Fuller et al., 1998). The total
yeast cellular extracts used for Western blot analyses
were prepared as previously described (Schaefer et al.,
2000). Cellular extracts were analyzed by SDS–polyac-
rylamide gel electrophoresis (PAGE) and immunoblotting
using an antibody directed to the hemagglutinin (HA) tag
present in Gal4 BD and Gal4 transcriptional activation
domain fusion proteins (12CA5; Boehringer Mannheim)
as described (Bell et al., 1998).
Coimmunoprecipitations
293T cells were electroporated with appropriate ex-
pression vectors and 48 h posttransfection were washed
once with PBS, scraped from the flask into 0.5 ml of PBS,
and lysed with the following lysis buffer: 1% Igepal; 1%
n-octyl glucoside; 150 mM NaCl; 100 mM Tris–Cl, pH 7.5;
aprotinin (0.076 TIU/ml); chymostatin (10 mg/ml); PMSF
800 mg/ml); and pepstatin (10 mg/ml). The cellular ly-
ates were briefly vortexed and centrifuged at 12,000 g to
emove insoluble debris. The supernatant was mixed
ith 10 ml of rabbit anti-human CD8 (H-160, Santa Cruz
iotechnology), rocked for 1 h at room temperature be-
ore adding 20 ml of Protein A Agarose (Sigma), and
ocked for a further hour at room temperature. The cap-
ured immune complexes were washed 6 times over a
-h period by pelleting at 12,000 g and resuspending in
resh lysis buffer. The immune complexes were pelleted
nd resuspended in 50 ml of SDS–PAGE gel loading
uffer. The soluble lysates and immunoprecipitated com-
lexes were resolved by SDS–PAGE, and the gels were
nalyzed directly with a fluorescence imager (FLA-2000,
uji Film).
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